The proliferation of antigen-specific lymphocytes and resulting clonal expansion are essential for adaptive immunity. We report here that B cell-specific deletion of the heavy chain of CD98 (CD98hc) resulted in lower antibody responses due to total suppression of B cell proliferation and subsequent plasma cell formation. Deletion of CD98hc did not impair early B cell activation but did inhibit later activation of the mitogen-activated protein kinase Erk1/2 and downregulation of the cell cycle inhibitor p27. Reconstitution of CD98hc-deficient B cells with CD98hc mutants showed that the integrin-binding domain of CD98hc was required for B cell proliferation but that the amino acid-transport function of CD98hc was dispensable for this. Thus, CD98hc supports integrin-dependent rapid proliferation of B cells. We propose that the advantage of adaptive immunity favored the appearance of CD98hc in vertebrates.
The proliferation of antigen-specific lymphocytes and resulting clonal expansion are essential for adaptive immunity. We report here that B cell-specific deletion of the heavy chain of CD98 (CD98hc) resulted in lower antibody responses due to total suppression of B cell proliferation and subsequent plasma cell formation. Deletion of CD98hc did not impair early B cell activation but did inhibit later activation of the mitogen-activated protein kinase Erk1/2 and downregulation of the cell cycle inhibitor p27. Reconstitution of CD98hc-deficient B cells with CD98hc mutants showed that the integrin-binding domain of CD98hc was required for B cell proliferation but that the amino acid-transport function of CD98hc was dispensable for this. Thus, CD98hc supports integrin-dependent rapid proliferation of B cells. We propose that the advantage of adaptive immunity favored the appearance of CD98hc in vertebrates.
Adaptive immunity is a vertebrate specialization that requires the selective proliferation of antigen-specific lymphocytes 1, 2 . The CD98 heavy chain (CD98hc; also called 4F2hc; A000262), encoded by Slc3a2, is a vertebrate membrane protein whose expression is much higher in proliferating lymphocytes 3 . Originally described 25 years ago as a lymphocyte-activation antigen 3 , the function of CD98hc in the immune system has remained obscure. CD98 has two distinct functions: facilitating amino acid transport 4, 5 and mediating integrin signaling 6, 7 . The 80-kilodalton CD98hc is covalently linked to one of several 40-kilodalton light chains, which function as amino acid transporters 4, 5 . Transport of leucine and isoleucine is mediated by the CD98 heterodimer 4, 5 ; these amino acids are important regulators of the mTOR pathway, which governs nutrient-regulated lymphocyte function 8, 9 . CD98hc also interacts with certain integrin b-subunits to mediate signaling events that control cell migration, survival and proliferation 7 . CD98hc is first found in primitive vertebrates, coincident with the appearance of adaptive immunity 2, 10 . Consequently, we hypothesized that CD98hc could be involved in the rapid lymphocyte proliferation required for effective adaptive immunity.
Here we report that CD98hc facilitates humoral immunity by supporting the rapid proliferation of B cells that is necessary for clonal expansion and subsequent differentiation into plasma cells. We deleted CD98hc in B cells by crossing mice bearing a loxP-flanked (floxed) Slc3a2 allele (Slc3a2 f/f ) with those expressing Cre recombinase in B cells (CD19-Cre + ). The resultant Slc3a2 f/f CD19-Cre + had normal maturation and distribution of peripheral B cells and normal morphology of secondary lymphoid organs. Slc3a2 f/f CD19-Cre + mice immunized with T cell-dependent or T cell-independent antigens had much lower antibody responses than did control Slc3a2 f/f mice without CD19-Cre, because of complete suppression of B cell proliferation and plasma cell formation by CD98hc-null B cells. A mutant form of CD98hc that mediates integrin signaling but not amino acid transport supported the proliferation of CD98hc-deficient B cells; hence, the region of CD98hc that mediates integrin interaction is required for B cell proliferation and the domain that facilitates the amino acidtransport function is dispensable for this. Furthermore, mitogenic stimulation of a mixture of CD98hc-deficient and CD98hc-sufficient B cells resulted in considerable enrichment for CD98hc-sufficient cells; this finding establishes the ability of CD98hc to confer a strong selective advantage during rapid B cell proliferation. Thus, the ability of CD98hc to enable clonal expansion, which is necessary for adaptive immunity, may have favored the appearance and retention of CD98hc in vertebrates 10 .
RESULTS

B cell CD98hc is needed for antibody responses
Because germline loss of CD98hc is embryonically lethal 11 , we targeted CD98hc by flanking exons 1 and 2 of Slc3a2 with loxP sites that specified Cre recombinase-mediated deletion of the cytoplasmic and transmembrane region of CD98hc ( Supplementary Fig. 1a online) , thus leading to complete loss of CD98hc expression 12 . We crossed Slc3a2 f/f mice with mice bearing Cre recombinase under control of the endogenous B cell-specific Cd19 locus 13 . The resulting Slc3a2 f/f CD19-Cre + mice had specific deletion of CD98hc in B lymphocytes beginning at the transition from pro-B cell to pre-B cell, when CD19 expression is first induced 14 . In the splenic B cell compartment, 70-90% of cells lacked CD98hc (Fig. 1a) , and we did not detect any deletion in T cells or monocytes-macrophages (Fig. 1b) , consistent with the efficiency and specificity of CD19-Cre-mediated recombination 13 . B cells from Slc3a2 flf littermates lacking CD19-Cre (Slc3a2 f/f CD19-Cre -mice) were uniformly positive for CD98hc (Fig. 1a) .
To assess whether CD98hc is important for the secretion of antibodies by B cells, we measured circulating immunoglobulin in Slc3a2 f/f CD19-Cre + and Slc3a2 f/f CD19-Cre -mice. Whereas basal circulating concentrations of immunoglobulin M (IgM) were not significantly lower (P 4 0.05) in naive Slc3a2 f/f CD19-Cre + mice, we noted significantly less (P o 0.025) class-switched IgG in these mice (Supplementary Fig. 1b) . Furthermore, after challenge with T cell-independent antigen in PBS (Fig. 2a) or T cell-dependent antigen in complete Freund's adjuvant (CFA; Fig. 2b ), we noted much lower antigenspecific IgM and IgG concentrations in Slc3a2 f/f CD19-Cre + mice than in Slc3a2 f/f CD19-Cre -mice. This defect was not specific to Toll-like receptor signals, because we obtained similar results after immunization with T cell-dependent antigens in adjuvant lacking microbial components (incomplete Freund's adjuvant; Fig. 2c ). In addition, this correlated with the 'gene dosage' of Slc3a2; Slc3a2 f/-CD19-Cre + mice had a more severe defect than did Slc3a2 f/+ CD19-Cre + mice (Supplementary Fig. 2 online) . Thus, B cell CD98hc is important for mounting specific antibody responses to antigenic challenge.
CD98hc is involved in integrin signaling, and integrins are involved in the localization and distribution of B cells subsets 15, 16 . In addition, CD98hc is important for integrinmediated migration of mesenchymal cells 7 . To test whether loss or misdistribution of B cell subsets could explain the impaired antibody production of Slc3a2 f/f CD19-Cre + mice, we examined lymphoid tissue for the presence and localization of B cell subsets. Despite the involvement of CD98hc in adhesive signaling and amino acid transport 6, 7, 17 , CD98hc-deficient follicular B cells, marginal zone B cells, transitional B cells and peritoneal B1 cells were present in normal percentages in the periphery; in addition, pro-B cells, pre-B cells, immature B cells, and mature B cells were present in normal proportions in the bone marrow (Fig. 3a) . Similarly, we detected no significant difference in the absolute numbers of these subsets in Slc3a2 f/f CD19-Cre + versus Slc3a2 f/f CD19-Cre -mice (P 4 0.05; Supplementary Fig. 3 online) . Slc3a2 f/f CD19-Cre + mice also had normal splenic architecture, as follicular B cells segregated with intact marginal zones, and Slc3a2 f/f CD19-Cre -and Slc3a2 f/f CD19-Cre + mice had similar numbers of germinal centers (Fig. 3b) . Finally, we detected no differences between naive Slc3a2 f/f CD19-Cre -and Slc3a2 f/f CD19-Cre + mice in terms of formed elements of the blood ( Supplementary Fig. 4 online) or the concentration of circulating natural IgM (Fig. 3c) . Thus, CD98hc is not required for the formation of mature B cells or their ability to populate secondary lymphoid organs.
B cell CD98hc is necessary for plasma cell formation B cells differentiate into antibody-secreting plasma cells after antigenic challenge, which suggests that a requirement for CD98hc in plasma cell formation might explain the lower humoral immune responses of Slc3a2 f/f CD19-Cre + mice. To test that idea, we purified resting splenic B cells from Slc3a2 f/f CD19-Cre + mice, depleted the population of any B cells expressing CD98hc and stimulated the remaining population with lipopolysaccharide (LPS) to induce the formation of plasma cells. B cells from Slc3a2 f/f CD19-Cre + mice were defective both in class switching ( Fig. 4a ) and in development into CD138 + plasma cells (Fig. 4b) . This phenotype bears similarities to that of b 1 integrin-deficient B cells 16 . The few plasma cells formed by Slc3a2 f/f CD19-Cre + B cells expressed CD98hc ( Supplementary Fig. 5 online), which indicated that they were the progeny of a few remaining CD98hc-expressing cells that had escaped Cre-mediated recombination and in vitro depletion. Indeed, when we omitted the step of in vitro depletion of CD98hc-expressing cells, the 10-20% of B cells that expressed CD98hc in Slc3a2 f/f CD19-Cre + mice generated near normal percentages of plasma cells in vitro ( Supplementary Figs. 6 and 7 online). Consistent with the defective formation of antibody-secreting plasma cells, B cells from Slc3a2 f/f CD19-Cre + mice also had impaired antibody secretion after LPS stimulation in vitro (Fig. 4c) . As shown by enzyme-linked immunospot assay, Slc3a2 f/f CD19-Cre + mice immunized with a T cell-dependent antigen also had fewer cells that secreted antigen-specific antibody immediately after isolation than did immunized Slc3a2 f/f CD19-Cre -mice (Fig. 4d) . These data collectively show that without CD98hc, B cells are considerably impaired in their ability to form plasma cells.
CD98hc is required for rapid B cell proliferation
Differentiation into plasma cells is preceded by many rounds of proliferation, which leads to larger numbers of antigen-specific B cells 18 ; class switching is also independently regulated by cell division 19 . Published reports using blocking or crosslinking antibody suggest that CD98hc is involved in the proliferation of T cells 20, 21 and keratinocytes 22 . To assess the function of CD98hc in B cell proliferation, we purified CD98hc-deficient or CD98hc-sufficient resting splenic B cells from Slc3a2 f/f CD19-Cre + or Slc3a2 f/f CD19-Cre -mice, respectively, labeled them with the intracellular dye CFSE, stimulated them with B cell mitogens and measured their proliferation by flow cytometry asessing dye dilution. By 5 d after stimulation, B cells from Slc3a2 f/f CD19-Cre -mice had divided five to eight times, as shown by discrete populations of daughter cells with exponential dilution of fluorescence (Fig. 5a ). In contrast, B cells from Slc3a2 f/f CD19-Cre + littermates showed minimal division in response to the B cell antigen receptor-crosslinking agent antibody to IgM (anti-IgM), provided alone or together with interleukin 4 (IL-4) or anti-CD40; we obtained similar data by directly counting viable cells ( Supplementary Fig. 8 Figure 3 Normal B cell distribution and natural antibody concentrations in mice did undergo one to two divisions in response to stimulation with a high dose of LPS (Fig. 5a) . However, those divided cells expressed CD98hc (Fig. 5b) , which suggests that they had escaped Cre-mediated deletion of Slc3a2. Thus, CD98hc is necessary for the rapid proliferation of mature B cells in response to antigen or other mitogenic signals. In the absence of stimulation, the lack of CD98hc did not appreciably alter the viability of cultured B cells (Supplementary Fig. 8 ), which suggests that the low CD98 expression in the resting state is not required for B cell survival. Thus, CD98hc is crucial for the rapid B cell population expansion and plasma cell formation in response to external stimuli that drive adaptive humoral immunity. CD98hc has two well documented biochemical functions. First, it interacts with certain integrin b-subunits to mediate integrin signaling 6, 23 and therefore influences adhesion-induced signaling events such as activation of the kinases pp125 FAK , PI(3)K and Akt and the adhesion molecule p130 CAS , which control cell proliferation 7 . In addition, by associating with CD98 light chains such as Lat-1, CD98hc facilitates the transport of amino acids such as leucine and isoleucine 4, 5 . These amino acids are important regulators of mTOR 24 , a critical 'node' in a signaling pathway that controls immune responses 8, 9 . Chimeric constructs in which portions of CD98hc are replaced with portions of CD69, another type II transmembrane protein, allow distinct separation of these two CD98hc functions 17 ( Fig. 6a) . We used such chimeras to identify the mechanism whereby CD98hc enables B cell proliferation.
To study the function of these chimeras in primary B cells, we infected bone marrow from Slc3a2 f/f CD19-Cre + mice with retrovirus containing bicistronic mRNA encoding either human CD98hc or a human CD98-CD69 chimera followed by an internal ribosomal entry site and a cassette encoding green fluorescent protein (GFP). We used these transduced bone marrow cells to reconstitute lethally irradiated recipient mice to create mice in which B cells that developed and continued to express a human CD98-CD69 chimera were marked by GFP fluorescence (Fig. 6a and Supplementary Figs. 9 and 10a online). Staining with an antibody specific for mouse CD98hc enabled us to identify B cells that lacked mouse CD98hc but expressed retrovirus-encoded human CD98hc chimeras; these cells were present in the blood beginning as early as 3 weeks after bone marrow transfer. Furthermore, all B cells that expressed GFP also stained for either human CD98hc or CD69 (Supplementary Fig. 10b ). At 6 weeks after bone marrow transfer, we purified resting CD98hc-null mouse splenic B cells, labeled them with the membrane dye DiD to monitor proliferation and stimulated them with LPS. Then, 4 d later, we analyzed proliferation by means of flow cytometry assessing dye dilution (Fig. 6b) . We found proliferation of B cells reconstituted with full-length human CD98hc or with the integrin-interacting chimera C98T98E69 (consisting of the cytoplasmic (C) domain of CD98hc, the transmembrane (T) domain of CD98hc and the extracellular (E) domain of CD69). In contrast, the C98T69E98 chimera, which interacts with Lat-1 and mediates isoleucine transport but does not interact with integrins, failed to reconstitute proliferation. Thus, the integrin-signaling portion of CD98hc is necessary and sufficient for the proliferation of mature B cells.
Loss of CD98hc inhibits integrin-dependent events
Integrin ligation leads to signals that result in cell spreading and migration 25 . In addition, integrins act in synergy with certain tyrosine kinase receptors to prolong and sustain activation of the mitogenactivated protein kinase Erk1/2, which promotes cell proliferation 26 by downregulating cyclin-dependent kinase inhibitors 27 and facilitating progression through the G1 phase of the cell cycle 28, 29 . B cells from Slc3a2 f/f CD19-Cre + mice had less phosphorylation of Erk1/2 at 17 h after BCR ligation (Fig. 7a) . In contrast, early activation (o1 h) of the kinases Erk1/2, Akt and Syk was intact in B cells lacking CD98hc ( Supplementary Fig. 11a-c online) , as was the expression of activation markers ( Supplementary Fig. 11d ). However, coincident with a failure to sustain Erk1/2 activation, Slc3a2 f/f CD19-Cre + B cells showed impaired downregulation of the cyclin-dependent kinase inhibitor p27 (Fig. 7b) , consistent with the observed lack of proliferation. Thus, the absence of CD98hc selectively impairs sustained activation of Erk1/2 after BCR ligation, an event known to depend on integrins in other cell types.
To directly assess the effect of CD98hc deficiency in B cells on another integrin-dependent function, we used a B cell adhesion and spreading assay 30, 31 . Activated B cells from Slc3a2 f/f CD19-Cre + mice failed to spread after direct antibody-mediated ligation of the integrin a L b 2 (LFA-1; Fig. 7c ). In contrast, CD98hc-bearing B cells from their Slc3a2 f/f CD19-Cre -littermates spread extensively, as shown by their twofold larger cell area and perimeter relative to that of the CD98hc-deficient B cells. In sum, these data point to the potential importance of integrin signaling in B cell proliferation.
As an initial test of that idea, we analyzed responses to crosslinking of the B cell antigen receptor on B cells from mice engineered to lack all leukocyte integrins 32 . Even though some of these B cells expressed a small quantity of integrin b 1 , they showed less proliferation in response to BCR ligation ( Supplementary Fig. 12 online) , which provides direct evidence of the involvement of integrins in B cell proliferation. The occurrence of some proliferation of these B cells raises the possibility that the loss of amino acid transport resulting from CD98hc deficiency may also contribute to the more profound defect in proliferation of CD98hc-deficient B cells.
CD98hc confers a selective advantage on B cells
During T cell-dependent responses, antigen-specific B cell populations expand in germinal centers in competition for limited antigen 33 . The experiments reported above indicated that CD98hc conferred a strong selective advantage during B cell population expansion in vitro. To measure that advantage in vivo, we immunized Slc3a2 f/f CD19-Cre + mice with trinitrophenyl-keyhole limpet hemocyanin (TNP-KLH), a T cell-dependent antigen, and analyzed CD98hc expression on splenic B cell subsets. In this experiment, CD98hc was present on less than 10% of resting splenic B cell subsets (Fig. 8a) . However, during the germinal center response, B cells undergo a proliferative burst and are selected for the ability to bind antigen with high affinity. At this stage, the percentage of CD98hc-expressing cells in the Slc3a2 f/f CD19-Cre + mice increased from less than 10% to 40% (Fig. 8a) . Furthermore, after class switching, over 99% of plasma cells in Slc3a2 f/f CD19-Cre + mice had detectable surface expression of CD98hc (Fig. 8a) . Thus, there were no detectable CD98-null plasma cells in Slc3a2 f/f CD19-Cre + mice; these observations are consistent with our in vitro finding that CD98hc was required for the rapid proliferation of mature B cells and subsequent formation of plasma cells. Slc3a2 f/f CD19-Cre + mice had considerably fewer germinal center B cells and plasma cells than Slc3a2 f/f CD19-Cre -mice had at 1 week after immunization (data not shown), probably because they had far fewer CD98hc-expressing precursor cells able to proliferate in germinal centers and form plasma cells. However, at 2-3 weeks after immunization, titers of antibodies specific for TNP-KLH in Slc3a2 f/f CD19-Cre + mice were similar to those in Slc3a2 f/f CD19-Cre -mice, probably because of germinal center selection for the few pre-existing CD98hc-expressing antigen-specific B cells ( Supplementary Fig. 13 online). This strong selection for CD98hc-expressing B cells can thus account for the relatively modestly lower basal serum IgG concentrations in Slc3a2 f/f CD19-Cre + mice. Immunohistochemical staining for CD98hc in spleens of immunized mice confirmed that, in contrast to the surrounding follicular B cells, germinal center B cells in Slc3a2 f/f CD19-Cre + mice expressed CD98hc (Fig. 8b) . In vitro analysis of B cells purified from Slc3a2 f/f CD19-Cre + mice without depletion of CD98-expressing cells provided further confirmation of the strong selective advantage conferred by CD98hc; after 4 d in culture, 99% of plasma cells expressed CD98hc (Fig. 8c) .
CD98hc is upregulated 20-to 30-fold after B cell activation, and we have shown here that CD98hc was required for B cells to proliferate and to differentiate into plasma cells. Hence, we propose that upregulation of CD98hc can serve as a checkpoint in the progression to humoral immunity. Consequently, the expression and function of CD98hc are potential targets for the modulation of antibody responses.
DISCUSSION
CD98hc was one of the earliest lymphocyte activation antigens described 3 , yet its function in the immune response has remained obscure. Although studies in which T cells were treated with antiCD98hc in vitro 20, 21, 34 have suggested that CD98hc is involved in T cell activation, the function of CD98hc in lymphocytes in vivo has remained unknown. Here we have shown that CD98hc is absolutely required for the rapid B cell clonal proliferation necessary for their subsequent differentiation into antibody-secreting plasma cells. Consequently, higher CD98hc expression provides antigen-stimulated B cells with a profound selective advantage.
The linkage of the integrin-binding function of CD98hc to B cell proliferation suggests a new paradigm for the function of integrin signaling in lymphocytes. In addition to functioning in hematopoiesis, trafficking and the formation of immune synapses 16, [35] [36] [37] [38] [39] , our work has indicated that integrin signaling is involved in clonal proliferation during immune responses. CD98hc serves two cellular functions; the first is amino acid transport, through interaction with one of several CD98 light chains 4, 5 . The extracellular domain of CD98hc is responsible for this function, and reconstitution with a chimeric protein containing this domain of CD98hc was not sufficient to restore the proliferation of CD98-null B cells. The second main function of CD98hc is mediating integrin signaling 6, 7 . The transmembrane and cytoplasmic domains of CD98hc are necessary for interaction with integrin b-subunits, which leads to pp125 FAK -dependent activation of Akt by PI(3)K and p130 CAS -mediated activation of the small GTPase Rac 7 . Reconstitution with a chimeric protein that contained only the transmembrane and cytoplasmic portions of CD98hc was sufficient to restore the proliferation of CD98hc-null B cells.
Integrins can act together with immunoreceptors, using similar 'downstream' signaling proteins, to promote lymphocyte proliferation and activation 40 . Thus, our findings establish a nexus of CD98hc-dependent integrin and immunoreceptor signaling pathways that regulate the proliferation of lymphocytes. CD98hc could function by allowing integrins to lower the threshold for cellular activation 41 by efficiently organizing components of the immunological synapse; however, we found that CD98hc was not required for early activation events. Instead, our data support a mechanism whereby CD98h-mediated integrin signals can extend the kinetics of immunoreceptor signals 42 to the point of driving cell division and clonal expansion.
Integrins drive fibroblast proliferation by sustaining Erk activation. Without integrin-mediated adhesion, growth factor signals are transient and are unable to downregulate cyclin-dependent kinase inhibitors such as p27, and cells fail to exit the G1 phase of the cell cycle 26, 28, 29 . Our data have indicated that a similar mechanism is operative in B cells. CD98hc-deficient B cells were able to generate early B cell antigen receptor signals but could not sustain late Erk1/2 signaling or downregulate p27 and failed to divide. The inability of CD98hc-deficient B cells to spread on integrin-specific antibodies confirmed the integrin signaling defect of CD98hc-deficient B cells. Published work using supported lipid bilayers or plate-bound antibodies 30 to study the formation of immunological synapses has shown that B cells spread rapidly after activation of the B cell antigen receptor in an integrin-dependent way 30, 43 ; we have now shown that this spreading is CD98hc dependent. Thus, CD98hc could promote integrin-dependent changes in cell shape that might stabilize interactions with antigen-bearing cells.
One implication of our work relates to the origin of the adaptive immune system. CD98hc orthologs first appeared in primitive vertebrates 10 , as did sequences in integrin b-cytoplasmic domains that permit CD98hc to interact with integrins 44 . The coincidence of those events with the appearance of adaptive immunity 2, 10 suggests that the survival advantage conferred by adaptive immunity was among the factors that favored the maintenance of CD98hc and its ability to mediate integrin signaling. CD98hc is overexpressed in many cancers and mediates tumorigenesis 7, [45] [46] [47] . In particular, published work has emphasized the importance of integrin signaling 25 in the development and maintenance of epithelial cancers 48, 49 and of CD98hc in potentiating the growth of cancer cells 7, 47 . Thus, the appearance of CD98hc in vertebrates, which enabled an adaptive immune response, may have led to greater susceptibility to cancer.
METHODS
Mice. Mice with floxed Slc3a2 were generated by flanking of exons 1 and 2, which encode the transmembrane portion of CD98hc, with loxP sites 12 . The neomycin-selection cassette used to select embryonic stem cell clones positive for a floxed Slc3a2 allele was flanked by Flp sites and thus was excised when mice with floxed Slc3a2 were bred with human b-actin FLPe deleter mice (Jackson Laboratories). Slc3a2 f/f CD19-Cre + mice were the result of crossing Slc3a2 f/f with the CD19-Cre + strain 13 . Slc3a2 f/+ CD19-Cre + offspring were identified by PCR and were backcrossed with Slc3a2 f/f mice to create mice heterozygous for CD19-Cre and homozygous for the Slc3a2 floxed allele (Slc3a2 f/f CD19-Cre -). This littermate comparison was used wherever possible. For Supplementary Figures 2 and 4 , the offspring of Slc3a2 +/-Â Slc3a2 f/f CD19-Cre + matings were used. All mice were housed at the University of California San Diego animal facility, and all experiments were approved by the Institutional Animal Care and Use Committee. 'Pan-integrin'-deficient mice were generated as described 32 Flow cytometry of B cell subsets. Bone marrow cells were prepared by dissection of femur and tibia bones from adult Slc3a2 f/f CD19-Cre + mice (10-20 weeks of age) and flushing with media with a 23-gauge needle. After two passages through the 23-gauge needle, erythrocytes were lysed for 8 min at 25 1C with ammonium chloride-potassium bicarbonate lysis buffer (Biowhittaker). Splenic single-cell suspensions were prepared by dissociation of whole spleens with a 7-ml tissue grinder (Kontes) and lysis of erythrocytes as described for bone marrow. Cells from peritoneal lavage were isolated from adult mice by flushing of the peritoneum with 10 ml complete medium (RPMI medium and 10% (vol/vol) FBS, supplemented with L-glutamine, penicillin and streptomycin) in batches of 1-2 ml. After being counted, bone marrow, spleen, or peritoneal cells were stained in 100 ml staining buffer (0.5% (wt/vol) BSA in PBS) containing fluorochrome-conjugated antibody to mouse B220 (RA3-6B2), IgM (II/41), CD21 (7G6), CD23 (B3B4), CD98hc (RL388), GL7 (GL7), CD138 (281-2) or Fas (Jo2) at optimal concentrations (all from BD Biosciences). After incubation of cells on ice for 30-45 min, followed by three washes in staining buffer, subsets were analyzed by flow cytometry with a FACSAria or FACSCalibur (BD Biosciences).
Immunohistochemistry. For analysis of CD98 selection after immunization, adult Slc3a2 f/f CD19-Cre + mice and littermate control (Slc3a2 f/f CD19-Cre -) mice were immunized intraperitoneally with 100 mg TNP-KLH (Biosearch) emulsified in CFA (250 ml). Then, 7 d later, spleens were embedded in TissueTek optimum cutting temperature compound (Sakura Finetek USA) and were frozen at À80 1C. Sections 8 mm in thickness were mounted on microscope slides, were fixed for 10 min in cold acetone, were blocked for 1 h with blocking buffer (0.5% (wt/vol) BSA in PBS), and were stained for 1 h at 25 1C with fluorescein isothiocyanate-conjugated peanut agglutinin (FL-1071; Vector Labs) and anti-B220 (BRA3-6B2), anti-CD5 (53-7.3), anti-CD3 (145-2C11) or anti-CD98 (RL388; all from BD Biosciences) or anti-MOMA-1 (MOMA-1; BaChem). After being washed with PBS containing 0.5% (vol/vol) Tween, sections were covered with Gel/Mount (Biomeda) and were sealed with glass coverslips. Images were acquired with Zeiss Axiocam M1 microscope (Zeiss) and Slidebook software (Intelligent Imaging Innovations).
Antibody analysis. For antigen-specific antibody responses, adult Slc3a2 f/f CD19-Cre + and control littermate Slc3a2 f/f CD19-Cre -mice were injected intraperitoneally with 50 mg TNP-LPS (Sigma) in 250 ml PBS (T cellindependent antigen) or 100 mg TNP-KLH (Biosearch) emulsified in 250 ml CFA (T cell-dependent antigen). Blood serum was collected by centrifugation of tail vein blood (100-200 ml with a solution of 1-2 mM EDTA as an anticoagulant) before and 1, 2 and 3 weeks after immunization. Concentrations of TNP-specific antibody in blood sera were assessed by direct enzyme-linked immunosorbent assay (ELISA) with TNP-ovalbumin as the coating antigen and alkaline phosphatase-conjugated polyclonal anti-mouse IgG (A4312; Sigma), polyclonal anti-mouse IgM (A7784; Sigma) or monoclonal anti-mouse IgG3 (R40-82; BD Biosciences) as the detection antibody. Because of inconsistencies in commercially available anti-TNP standards, the ELISA data in Figure 2 and Supplementary Figure 13 were quantified by multiplication of the absorbance 'reading out' of three to four dilutions of sample that was in the linear portion of the assay with the dilution factor to obtain the values presented. Concentrations of circulating IgG and IgM from naive mice and from in vitro splenic B cell stimulations were measured by sandwich ELISA with polyclonal anti-mouse IgG (715-005-150) or anti-mouse IgM (115-006-020; both from Jackson Immunoresearch), the detection antibodies described for the direct ELISA and standard curves obtained with purified polyclonal IgG or IgM.
In vitro proliferation and differentiation of resting B cells. Resting B cells (defined as CD43 -) were purified from spleen cell suspensions of Slc3a2 f/f CD19-Cre + , 'pan-integrin'-deficient or wild-type control mice by depletion of CD43 + cells (and depletion of CD98hc + B cells for Slc3a2 f/f CD19-Cre + mice or depletion of b 1 integrin-positive cells for 'pan-integrin'-deficient mice) with B cell magnetic beads (Dynal). Purity was routinely 95-98%, as assessed by staining with anti-B220 (RA3-6B2) or anti-CD43 (eBioR2-60) and flow cytometry. Resting B cells were plated in 48-well plates at a density of 4 Â 10 5 cells per well and were stimulated for 3-5 d with Ultrapure LPS (20 mg/ml; InVivoGen), F(ab¢) 2 goat anti-mouse IgM (30 mg/ml; Jackson Immunoresearch), anti-CD40 (2 mg/ml; 3/23; BD Biosciences) or recombinant mouse IL-4 (50 ng/ml; Peprotech). Unstimulated resting cells were cultured with medium alone. Staining with anti-CD138 (DL-101; eBioscience), antiIgG3 (R40-82; BD Biosciences) and anti-B220 (RA3-6B2; eBioscience) and flow cytometry were used to assess class switching and differentiation into plasma cells. For measurement of proliferation, purified resting B cells were labeled with 2 mM CFSE (carboxyfluorescein diacetate succinimidyl ester; Molecular Probes) and were analyzed by flow cytometry at 3-5 d for dilution of fluorescence (cell division). Because the extent of CFSE labeling varied among samples, unstimulated cells were also assessed (Supplementary Fig. 12 ). For some differentiation or proliferation experiments, cells were also stained with anti-CD98 (RL388; eBioscience). Propidium iodide exclusion and automated counting by flow cytometry were used for analysis of the expansion of cell populations. In this in vitro culture system, many cells die or are lost during collecting or staining and a smaller subset divides rapidly.
Retroviral infection of mouse bone marrow and transplantation into recipient mice. The bone marrow transplant protocol was from S. Rowland in the lab of R. Pelanda. Donor mice were treated intraperitoneally with 5-fluorouracil (Adrucil; Sicor Pharmaceuticals) in 200 ml PBS at a dose of 4 mg per mouse. Then, 3 d later, EcoPack 293 packaging cells (Imgenex) were transfected with pCl-Eco (Imgenex) and one of four retroviral constructs (C98T98E98, C98T69E98, C98T98E69 or C69T69E69, on a backbone of MSCV-IRES-GFP) 50 , followed by culture for 48 h. On day 4, donor mice were killed and bone marrow was cultured overnight in complete medium containing IL-3 (25 ng/ml), IL-6 (50 ng/ml) and stem cell factor (50 ng/ml; all from Peprotech). Viral supernatants were collected from packaging cells on day 5 and were used to 'spin-infect' bone marrow on days 5 and 6 for 90 min at 1,000g and at 25 1C. Bone marrow cells were collected on day 7 and were injected intravenously at a dose of 2.5 Â 10 5 cells in 100 ml PBS per mouse. Small samples were retained and were stained with antibody to Sca-1 (D7; eBioscience), a marker of stem cells. In all samples, 24-29% of Sca-1 + populations were GFP + before injection. At 6-8 weeks after transplantation, resting B cells deficient in mouse CD98hc were purified from spleens of recipient mice, then were labeled and were stimulated with LPS. Proliferation and plasma cell differentiation was assessed as described above but with DiD (1,1¢-dioctadecyl-3,3,3¢,3¢-tetramethylindodicarbocyanine; Molecular Probes), which emits in a range distinct from that of GFP.
Additional methods. Information on hematology, enzyme-linked immunospot assays, spreading assays, signaling and statistical analysis is available in the Supplementary Methods online.
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